Literature DB >> 7694686

Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts.

K Bradstock1, V Makrynikola, A Bianchi, K Byth.   

Abstract

Normal B lymphopoiesis is dependent on a close relationship between B-cell precursors and the bone marrow (BM) microenvironment. To further understand the mechanisms regulating the proliferation of the malignant counterpart of B-cell precursors, namely precursor-B acute lymphoblastic leukemia (ALL), we examined the adhesion to BM fibroblasts (BMF) of 19 cases of precursor-B ALL using a chromium labeling assay. Eleven of 19 cases showed greater than 10% binding to BMF (range 2.3% to 54.8%, mean 19.1%). Binding was increased approximately twofold by preincubation of BMF with tumor necrosis factor and interleukin-4, which also resulted in upregulation of expression of vascular cell adhesion molecule-1 (VCAM-1) on BMF. The mechanism of attachment was investigated using murine monoclonal antibodies to leukocyte integrins, principally the beta, integrins VLA-4 and VLA-5, which were demonstrated to be present on most cases by flow cytometry. Statistically significant inhibition of adhesion was observed with antibodies to the beta 1 common subunit, VLA-4, and VLA-5, whereas little effect was seen with antibodies to VLA-6 or the beta 2 integrin subunit. Preincubation of fibroblasts with an antibody to VCAM-1 (a ligand of VLA-4) inhibited leukemic cell binding in the majority of cases, which was an effect also observed on cytokine-stimulated BMF. However, a minority of cases, as well as the pre-B lines NALM-6 and KM-3, showed no evidence of inhibition of adhesion with anti-VCAM-1 antibodies. Treatment of BMF with antifibronectin antibody alone had little effect on ALL adhesion and did not enhance the inhibitory effect of anti-VCAM-1. These data indicate that precursor-B ALL cells bind to BM stroma through the beta 1 integrins VLA-4 and VLA-5 and that this effect is partly mediated by VCAM-1 on stromal cells, although other undefined VLA ligands are also likely to be involved. Attachment of ALL cells to stroma is likely to play a key role in regulating the survival and growth of these cells through exposure to stromal cytokines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694686

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.

Authors:  R Dolcetti; R Giardini; C Doglioni; R Cariati; F Pomponi; C D'Orazi; S Rao; A I Lazarovits; E C Butcher; M Boiocchi
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

Authors:  Sonali P Barwe; Anthony Quagliano; Anilkumar Gopalakrishnapillai
Journal:  Semin Oncol       Date:  2017-07-11       Impact factor: 4.929

Review 3.  The bone marrow microenvironment and leukemia: biology and therapeutic targeting.

Authors:  Edward Allan R Sison; Patrick Brown
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

Review 4.  Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.

Authors:  Edward Allan Racela Sison; Peter Kurre; Yong-Mi Kim
Journal:  Pediatr Hematol Oncol       Date:  2017-12-06       Impact factor: 1.969

5.  Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support.

Authors:  Jeannette Boutter; Yun Huang; Blerim Marovca; Andreas Vonderheit; Michael A Grotzer; Cornelia Eckert; Gunnar Cario; Bernd Wollscheid; Peter Horvath; Beat C Bornhauser; Jean-Pierre Bourquin
Journal:  Oncotarget       Date:  2014-11-30

6.  Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.

Authors:  Edward Allan R Sison; Daniel Magoon; Li Li; Colleen E Annesley; Rachel E Rau; Donald Small; Patrick Brown
Journal:  Oncotarget       Date:  2014-10-15

Review 7.  Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Marjorie C Delahaye; Kaoutar-Insaf Salem; Jeoffrey Pelletier; Michel Aurrand-Lions; Stéphane J C Mancini
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

Review 8.  The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia.

Authors:  Lauren K Meyer; Michelle L Hermiston
Journal:  Cancer Drug Resist       Date:  2019-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.